CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-23 | AFEYAN NOUBAR Director | Sale 10b5-1 | −311 | $112.61 | $35K | 2,026,898 |
| 2023-08-23 | AFEYAN NOUBAR Director | Sale 10b5-1 | −854 | $113.83 | $97K | 2,026,044 |
| 2023-08-23 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,657 | $115.16 | $421K | 2,022,387 |
| 2023-08-23 | AFEYAN NOUBAR Director | Sale 10b5-1 | −9,878 | $115.84 | $1.1M | 2,012,509 |
| 2023-08-23 | AFEYAN NOUBAR Director | Sale 10b5-1 | −300 | $116.46 | $35K | 2,012,209 |
| 2023-08-17 | Hoge Stephen President | Sale 10b5-1 | −15,000 | $100.00 | $1.5M | 1,587,579 |
| 2023-08-16 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,600 | $95.70 | $153K | 2,035,609 |
| 2023-08-16 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,900 | $96.44 | $280K | 2,032,709 |
| 2023-08-16 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,200 | $98.07 | $118K | 2,031,509 |
| 2023-08-16 | AFEYAN NOUBAR Director | Sale 10b5-1 | −4,000 | $98.82 | $395K | 2,027,509 |
| 2023-08-16 | AFEYAN NOUBAR Director | Sale 10b5-1 | −300 | $99.50 | $30K | 2,027,209 |
| 2023-08-10 | Hoge Stephen President | Sale 10b5-1 | −247 | $102.53 | $25K | 1,602,579 |
| 2023-08-09 | Hoge Stephen President | Exercise or conversion 10b5-1 | +523 | 1,602,826 | ||
| 2023-08-09 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −523 | 3,134 | ||
| 2023-08-02 | AFEYAN NOUBAR Director | Sale 10b5-1 | −9,725 | $110.59 | $1.1M | 2,042,484 |
| 2023-08-02 | AFEYAN NOUBAR Director | Sale 10b5-1 | −4,175 | $111.46 | $465K | 2,038,309 |
| 2023-08-02 | AFEYAN NOUBAR Director | Sale 10b5-1 | −900 | $112.59 | $101K | 2,037,409 |
| 2023-08-02 | AFEYAN NOUBAR Director | Sale 10b5-1 | −200 | $113.68 | $23K | 2,037,209 |
| 2023-07-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,400 | $119.61 | $287K | 2,064,809 |
| 2023-07-26 | AFEYAN NOUBAR Director | Sale 10b5-1 | −11,499 | $120.50 | $1.4M | 2,053,310 |
Page 40 of 66 · 1,314 trades